The Use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence

The Use of Disease-Modifying Therapies in Multiple
Sclerosis:
Principles and Current Evidence

Dear
Colleagues,

The Consortium of MS Centers collaborated with the seven other member
organizations of the MS Coalition to develop a paper that summarizes
current evidence about disease modification in multiple sclerosis and
provides support for broad access to U.S. Food and Drug
Administration-approved MS disease-modifying therapies for people
with MS in the United States. The paper was reviewed by nine external
reviewers and subsequently endorsed by all eight MS Coalition
organizations.

The document
will serve as a valuable tool for professionals engaged in MS care. A
summary document is currently in development for general audiences
and once completed, will be distributed to all of our members.

Please find the two versions of
the document-a full color and a grey scale version for your review
and download. Please feel free to share with others!